<DOC>
	<DOCNO>NCT01168310</DOCNO>
	<brief_summary>This randomize , double-blind , multi-dose , parallel group trial ass pharmacodynamic response fluticasone propionate formoterol fumarate subject COPD .</brief_summary>
	<brief_title>A Trial Assess Pharmacodynamic Response Subjects With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Able understand requirement study provide write informed consent A clinical diagnosis COPD A current prior history least 10pack year cigarette smoke Women childbearing potential ( WOCBP ) must negative pregnancy test screen visit agree avoid become pregnant duration study A clinical diagnosis Asthma Other significant disease COPD Subjects radiation chemotherapy within previous 12 month Subjects lung resection QTcB great 0.460 second History illegal drug abuse alcohol abuse within past 5 year</criteria>
	<gender>All</gender>
	<minimum_age>40 Days</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Pulmonary , Obstructive , lung , COPD</keyword>
</DOC>